United Orthopedic Corporation (TPEX:4129)
Taiwan · Delayed Price · Currency is TWD 101.00
-0.50 (-0.49%)
At close: Mar 27, 2026
United Orthopedic Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,655 | 4,653 | 3,930 | 3,169 | 2,571 | |
Revenue Growth (YoY) | 21.54% | 18.40% | 24.02% | 23.25% | 9.76% |
Cost of Revenue | 1,256 | 1,031 | 893.52 | 805.7 | 729.52 |
Gross Profit | 4,400 | 3,622 | 3,036 | 2,363 | 1,841 |
Selling, General & Admin | 3,400 | 2,778 | 2,315 | 1,847 | 1,538 |
Research & Development | 262.54 | 220.49 | 185.03 | 167.26 | 143.68 |
Other Operating Expenses | -7.27 | -0.2 | -15.01 | 7.27 | -1.91 |
Operating Expenses | 3,659 | 3,013 | 2,493 | 2,021 | 1,680 |
Operating Income | 740.72 | 608.99 | 543.27 | 341.58 | 161.43 |
Interest Expense | -45.95 | -43.19 | -44.14 | -24.11 | -17.64 |
Interest & Investment Income | 15.52 | 12.72 | 9 | 6.29 | 2.01 |
Earnings From Equity Investments | -66.23 | -71.3 | -76.42 | -94.64 | -49.5 |
Currency Exchange Gain (Loss) | - | 32.37 | 33.64 | 46.07 | -44.18 |
Other Non Operating Income (Expenses) | 112.34 | 33.86 | 44.05 | 25.64 | 21.29 |
EBT Excluding Unusual Items | 756.4 | 573.45 | 509.41 | 300.84 | 73.41 |
Gain (Loss) on Sale of Assets | - | 1.66 | -0.18 | 0.59 | 1.18 |
Other Unusual Items | - | - | - | 1.59 | - |
Pretax Income | 756.4 | 575.1 | 509.23 | 303.02 | 74.59 |
Income Tax Expense | 184.93 | 114.72 | 120.92 | 79.44 | 21.72 |
Earnings From Continuing Operations | 571.47 | 460.38 | 388.31 | 223.58 | 52.88 |
Minority Interest in Earnings | -8.97 | -3.95 | -4.11 | -2.05 | -0.61 |
Net Income | 562.5 | 456.43 | 384.2 | 221.53 | 52.27 |
Preferred Dividends & Other Adjustments | - | 0.47 | 4.58 | - | 23.4 |
Net Income to Common | 562.5 | 455.96 | 379.62 | 221.53 | 28.87 |
Net Income Growth | 23.24% | 18.80% | 73.43% | 323.82% | -48.67% |
Shares Outstanding (Basic) | 96 | 96 | 84 | 78 | 78 |
Shares Outstanding (Diluted) | 99 | 96 | 93 | 88 | 78 |
Shares Change (YoY) | 3.23% | 3.31% | 5.60% | 12.77% | -11.73% |
EPS (Basic) | 5.83 | 4.74 | 4.50 | 2.84 | 0.37 |
EPS (Diluted) | 5.67 | 4.74 | 4.18 | 2.51 | 0.37 |
EPS Growth | 19.62% | 13.41% | 66.51% | 578.38% | -60.53% |
Free Cash Flow | 338.68 | 192.95 | -79.48 | 53.66 | 142.58 |
Free Cash Flow Per Share | 3.41 | 2.01 | -0.85 | 0.61 | 1.82 |
Dividend Per Share | - | 4.000 | 4.000 | 2.500 | - |
Dividend Growth | - | - | 60.00% | - | - |
Gross Margin | 77.79% | 77.85% | 77.26% | 74.57% | 71.62% |
Operating Margin | 13.10% | 13.09% | 13.82% | 10.78% | 6.28% |
Profit Margin | 9.95% | 9.80% | 9.66% | 6.99% | 1.12% |
Free Cash Flow Margin | 5.99% | 4.15% | -2.02% | 1.69% | 5.55% |
EBITDA | 1,280 | 1,030 | 902.52 | 641.25 | 437.97 |
EBITDA Margin | 22.63% | 22.13% | 22.96% | 20.24% | 17.04% |
D&A For EBITDA | 538.86 | 420.54 | 359.25 | 299.67 | 276.55 |
EBIT | 740.72 | 608.99 | 543.27 | 341.58 | 161.43 |
EBIT Margin | 13.10% | 13.09% | 13.82% | 10.78% | 6.28% |
Effective Tax Rate | 24.45% | 19.95% | 23.75% | 26.22% | 29.11% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.